Ignite Creation Date:
2024-05-06 @ 1:48 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01906385
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2012-01-11
Brief Title:
Maximum Tolerated Dose Safety and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma ReSPECT
Sponsor:
Plus Therapeutics
Organization:
Plus Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2012-01-11
First Submit QC Date:
July 19 2013
Study First Post Date:
2013-07-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL